Vista Pharmaceuticals has closed its trading window, effective July 1st.

This measure restricts designated individuals and their immediate relatives from trading company shares.

The window will reopen 48 hours after the financial results for the quarter ending June 30, 2026, are announced.

This is a standard step to ensure fair trading practices and prevent insider activity ahead of earnings.

The company will soon announce the board meeting date to approve these results.